Evidence map›Paper›PMID 21312313›Full record

ReviewDevelopmental dynamics : an official publication of the American Association of Anatomists2011

Facultative stem cells in liver and pancreas: fact and fancy.

Kilangsungla Yanger, Ben Z Stanger

Abstract readReview
In one paragraph

Review in Developmental dynamics : an official publication of the American Association of Anatomists, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Infantile hemangioma models: is the needle in a haystack?Journal of translational medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Spatial heterogeneity in the mammalian liver.Nature reviews. Gastroenterology & hepatology · 2019
    Review
  11. p53 on the crossroad between regeneration and cancer.Cell death and differentiation · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kilangsungla Yanger
Ben Z Stanger

Funding

Mechanisms of bile duct reprogrammingR01DK083355 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GROMPE, MARKUS, STANGER, BEN Z · 2009 to 2020
$4.3M
Immunobiology and immunotherapy of pancreatic cancerR01CA169123 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STANGER, BEN Z, VONDERHEIDE, ROBERT H · 2012 to 2016
$3.1M
Notch Signaling and Cell Fate in Embryonic and Adult LiverR03DK076583 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI STANGER, BEN Z · 2007 to 2008
$156k
NCI NIH HHS R01 CA169123NIDDK NIH HHS R01 DK083355NIDDK NIH HHS R03 DK076583
6 · The paper itself

Abstract

Tissue turnover is a regular feature of higher eukaryotes, either as part of normal wear and tear (homeostasis) or in response to injury (regeneration). Cell replacement is achieved either through replication of existing cells or differentiation from a self-renewing pool of stem cells. The major distinction regards cellular potential, because stem cells by definition have a capacity to differentiate, while replication implies that cells adopt a single fate under physiologic conditions. A hybrid model, the facultative stem cell (FSC) model, posits that tissues contain cells that normally exhibit unipotency but have the capacity to function as stem cells upon injury. The FSC paradigm is well established in urodele amphibians, but the nature and role of FSCs in mammals is less defined. Here, we review the evidence for FSCs in two mammalian organs, the liver and the pancreas, and discuss alternative models that could account for regeneration in these organs.

Indexed as

AnimalsHumansLiverLiver RegenerationPancreasStem Cells

Identifiers

PMID21312313
PMCPMC4667725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.